Apollon Formularies plc Announces Chief Science Officer Appointed as Board Director

27.01.2022 - Apollon Formularies Announces Appointment of Dr. Herbert Fritsche, Former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at the University of Texas, MD Anderson Cancer Center in Houston, Texas to the Board of Directors• ... Seite 1

Related Keywords

Houston ,Texas ,United States ,United Kingdom ,London ,City Of ,University Of Texas ,American ,Mortonk Schwartz ,Herbert Fritsche ,National Cancer Institute ,American Association For Clinical Chemistry ,Drug Administration ,Md Anderson Cancer Center ,Award For Outstanding Research In Oncology ,Johnson Award For Outstanding Research ,National Award For Contributions ,Expert Panel ,Professor Of Laboratory Medicine ,National Academy Of Clinical Biochemistry ,Immunology Division ,Clinical Ligand Assay Society ,York Metro Division ,Apollon Formularies ,Clinical Chemist ,Laboratory Medicine ,Clinical Chemistry Section ,Cancer Center ,Laboratory Practice Guidelines Committee ,National Academy ,Clinical Biochemistry ,Editorial Board ,Tumor Marker Practice Guidelines ,American Society ,Clinical Oncology ,Johnson Award ,Outstanding Research ,Mortonk Schwartz Award ,Outstanding Achievements ,Cancer Diagnostics ,American Association ,Clinical Chemistry ,Jolliff Award ,Lifetime Achievements ,New York Metro Division ,Outstanding Clinical Chemist Award ,Texas Section ,National Award ,Excellence Award ,Texas Graduate School ,Biomedical Science ,Distinguished Scientist Award ,